OWP Pharmaceuticals Announces IND Approval for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder
07 oct. 2020 08h00 HE
|
OWP Pharmaceuticals
NAPERVILLE, Ill., Oct. 07, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Peer Specialist Chronicles His Epic Faith Journey and Experiences With Bipolar Disorder in Uplifting Collection of Poetry and Prose
20 juil. 2020 07h00 HE
|
AuthorHouse
MILWAUKEE, July 20, 2020 (GLOBE NEWSWIRE) -- Making sense of a world that often makes no sense at all is one of life’s greatest challenges. In his book “55 Reflections of a Searching Skeptic:...
Author Reflects on Inspiring Journey of Spiritual Growth, Shares Experiences Healing from Bipolar Disorder in Debut Memoir
13 juil. 2020 08h00 HE
|
XlibrisUS
NAPLES, Fla., July 13, 2020 (GLOBE NEWSWIRE) -- Author Bárbaro Baez Alvarez has published his debut, inspirational self-help memoir that twines his journey of spiritual growth with his experiences...
OWP Pharmaceuticals Announces Pre-IND Acknowledgement and Patent Application for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder
08 janv. 2020 08h00 HE
|
OWP Pharmaceuticals
NAPERVILLE, Ill., Jan. 08, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
OWP Pharmaceuticals Announces a Second IND Approval and Patent Application: The First-Ever Liquid Oral Suspension Formulation of Lamotrigine for the Treatment of Epilepsy and Bipolar Disorder
03 déc. 2019 08h00 HE
|
OWP Pharmaceuticals
NAPERVILLE, Ill., Dec. 03, 2019 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Neuroleptics Market To Reach USD 15.41 Billion By 2026 | Reports And Data
15 avr. 2019 12h39 HE
|
Reports And Data
Increase in health awareness is expected to be a prime factor driving the market growth; the rising incidences of mental disorders are also expected to grow the market demand in the future. Market...